In the subjects with NASH, the production of triglyceride-rich VLDL particles in the liver or lipolysis is not suppressed by insulin, leading to an increase in serum triglyceride levels [17]. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.